Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.

O Clegg, D; J Reda, D; H Weisman, M; D Blackburn, W; J Cush, J; W Cannon, G; L Mahowald, M; R Schumacher, H; Taylor, T; Budiman-Mak, E; R Cohen, M; B Vasey, F; E Luggen, M; Mejias, E; L Silverman, S; Makkena, R; P Alepa, F; Buxbaum, J; M Haakenson, C; H Ward, R; J Manaster, B; J Anderson, R; R Ward, J; G Henderson, W

doi:10.1002/art.1780391209

Public

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.

Shared by NobleBlocks on Dec 1, 1996 • 12:00 AM UTC

Authors:

D O Clegg

D J Reda

M H Weisman

Abstract

OBJECTIVE: To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with nonsteroidal antiinflammatory drug therapy. METHODS: Two hundred sixty-four patients with AS were recruited from 15 clinics...

Discussions